- Fellowship - National Institutes of Health (2003-2006), Infectious Diseases
- Residency - Baylor College of Medicine (2002-2003), Internal Medicine
- Residency - Baylor College of Medicine (1999-2002), Internal Medicine
- Medical School - Baylor College of Medicine (1995-1999)
- University - Johns Hopkins Bloomberg School of Public Health (1991-1995)
New Patient Appointment or 214-645-8300
David Greenberg, M.D.
- Distinguished Teaching Professor
- Internal Medicine - Infectious Diseases and Geographic Medicine
Education & Training
Professional Associations & Affiliations
- Society for Leukocyte Biology
- Infectious Diseases Society of America
- American Society for Microbiology
Honors & Awards
- National Institutes of Health 2006, Fellows Award for Research Excellence
- Excellence in Education Award UTSW 2011
- Excellence in Education Award 2013
- Southwestern Association of Teachers 2014
- Regents' Outstanding Teacher Award 2014
Books & Publications
-
Publications
-
Peptide-conjugated phosphorodiamidate morpholino oligomer (PPMO) restores carbapenem susceptibility to NDM-1-positive pathogens in vitro and in vivo.
Sully EK, Geller BL, Li L, Moody CM, Bailey SM, Moore AL, Wong M, Nordmann P, Daly SM, Sturge CR, Greenberg DE The Journal of antimicrobial chemotherapy 2016 Dec -
Burkholderia cenocepacia J2315 escapes to the cytosol and actively subverts autophagy in human macrophages.
Al-Khodor S, Marshall-Batty K, Nair V, Ding L, Greenberg DE, Fraser ID Cellular microbiology 2013 Oct -
A novel bacterium associated with lymphadenitis in a patient with chronic granulomatous disease
Greenberg DE, Ding L, Zelazny AM, Stock F, Wong A, Anderson VL, Miller G, Kleiner DE, Tenorio AR, Brinster L, Dorward DW, Murray PR, Holland SM. PLoS Pathogens April 2006 2(4) e28 -
Inhibition of Pseudomonas aeruginosa by Peptide-conjugated Phosphorodiamidate Morpholino Oligomers.
Howard JJ, Sturge CR, Moustafa DA, Daly SM, Marshall-Batty KR, Felder CF, Zamora D, Yabe-Gill M, Labandeira-Rey M, Bailey SM, Wong M, Goldberg JB, Geller BL, Greenberg DE Antimicrobial agents and chemotherapy 2017 Jan -
Sequence-Specific Targeting of Bacterial Resistance Genes Increases Antibiotic Efficacy.
Ayhan DH, Tamer YT, Akbar M, Bailey SM, Wong M, Daly SM, Greenberg DE, Toprak E PLoS biology 2016 Sep 14 9 e1002552 -
Primary osteomyelitis caused by hypervirulent Klebsiella pneumoniae.
Prokesch BC, TeKippe M, Kim J, Raj P, TeKippe EM, Greenberg DE The Lancet. Infectious diseases 2016 Jul -
Gene-silencing antisense oligomers inhibit acinetobacter growth in vitro and in vivo.
Geller BL, Marshall-Batty K, Schnell FJ, McKnight MM, Iversen PL, Greenberg DE The Journal of infectious diseases 2013 Nov 208 10 1553-60 -
Signal transducer and activator of transcription 1 (STAT1) gain-of-function mutations and disseminated coccidioidomycosis and histoplasmosis.
Sampaio EP, Hsu AP, Pechacek J, Bax HI, Dias DL, Paulson ML, Chandrasekaran P, Rosen LB, Carvalho DS, Ding L, Vinh DC, Browne SK, Datta S, Milner JD, Kuhns DB, Long Priel DA, Sadat MA, Shiloh M, De Marco B, Alvares M, Gillman JW, Ramarathnam V, de la Morena M, Bezrodnik L, Moreira I, Uzel G, Johnson D, Spalding C, Zerbe CS, Wiley H, Greenberg DE, Hoover SE, Rosenzweig SD, Galgiani JN, Holland SM The Journal of allergy and clinical immunology 2013 Mar -
Innate immunity against Granulibacter bethesdensis, an emerging gram-negative bacterial pathogen.
Zarember KA, Marshall-Batty KR, Cruz AR, Chu J, Fenster ME, Shoffner AR, Rogge LS, Whitney AR, Czapiga M, Song HH, Shaw PA, Nagashima K, Malech HL, DeLeo FR, Holland SM, Gallin JI, Greenberg DE Infection and immunity 2012 Mar 80 3 975-81 -
Recurrent Granulibacter bethesdensis infections and chronic granulomatous disease.
Greenberg DE, Shoffner AR, Zelazny AM, Fenster ME, Zarember KA, Stock F, Ding L, Marshall-Batty KR, Wasserman RL, Welch DF, Kanakabandi K, Sturdevant DE, Virtaneva K, Porcella SF, Murray PR, Malech HL, Holland SM Emerging infectious diseases 2010 Sep 16 9 1341-8 -
Granulibacter bethesdensis gen. nov., sp. nov., a distinctive pathogenic acetic acid bacterium in the family Acetobacteraceae.
Greenberg DE, Porcella SF, Stock F, Wong A, Conville PS, Murray PR, Holland SM, Zelazny AM International journal of systematic and evolutionary microbiology 2006 Nov 56 Pt 11 2609-16 -
A novel bacterium associated with lymphadenitis in a patient with chronic granulomatous disease.
Greenberg DE, Ding L, Zelazny AM, Stock F, Wong A, Anderson VL, Miller G, Kleiner DE, Tenorio AR, Brinster L, Dorward DW, Murray PR, Holland SM PLoS pathogens 2006 Apr 2 4 e28 -
Markers of inflammation in bacterial diarrhea among travelers, with a focus on enteroaggregative Escherichia coli pathogenicity.
Greenberg DE, Jiang ZD, Steffen R, Verenker MP, DuPont HL The Journal of infectious diseases 2002 Apr 185 7 944-9 -
Peptide-conjugated phosphorodiamidate morpholino oligomers: a new strategy for tackling antibiotic resistance.
Geller BL, Greenberg DE Therapeutic delivery 2014 Mar 5 3 243-5 -
Methylotroph Infections and Chronic Granulomatous Disease.
Falcone EL, Petts JR, Fasano MB, Ford B, Nauseef WM, Neves JF, Simões MJ, Tierce ML, de la Morena MT, Greenberg DE, Zerbe CS, Zelazny AM, Holland SM Emerging infectious diseases 2016 Mar 22 3 404-9 -
Microbiological culture methods for pediatric musculoskeletal infection: a guideline for optimal use.
Section J, Gibbons SD, Barton T, Greenberg DE, Jo CH, Copley LA The Journal of bone and joint surgery. American volume 2015 Mar 97 6 441-9 -
Acinetobacter infections and outcomes at an academic medical center: a disease of long-term care.
Townsend J, Park AN, Gander R, Orr K, Arocha D, Zhang S, Greenberg DE Open forum infectious diseases 2015 Jan 2 1 ofv023 -
Simultaneous Host-Pathogen transcriptome analysis during Granulibacter bethesdensis infection of normal and chronic granulomatous disease neutrophils.
Greenberg DE, Sturdevant DE, Marshall-Batty KR, Chu J, Pettinato AM, Virtaneva K, Lane J, Geller BL, Porcella SF, Gallin JI, Holland SM, Zarember KA Infection and immunity 2015 Aug -
Pulmonary nontuberculous mycobacterial disease: prospective study of a distinct preexisting syndrome.
Kim RD, Greenberg DE, Ehrmantraut ME, Guide SV, Ding L, Shea Y, Brown MR, Chernick M, Steagall WK, Glasgow CG, Lin J, Jolley C, Sorbara L, Raffeld M, Hill S, Avila N, Sachdev V, Barnhart LA, Anderson VL, Claypool R, Hilligoss DM, Garofalo M, Fitzgerald A, Anaya-O'Brien S, Darnell D, DeCastro R, Menning HM, Ricklefs SM, Porcella SF, Olivier KN, Moss J, Holland SM American journal of respiratory and critical care medicine 2008 Nov 178 10 1066-74 -
Host-microbe interaction systems biology: lifecycle transcriptomics and comparative genomics
Sturdevant DE, Virtaneva K, Martens C, Bozinov D, Ogundare O, Castro N, Kanakabandi K, Beare PA, Omsland A, Carlson JH, Kennedy AD, Heinzen RA, Celli J, Greenberg DE, DeLeo FR, Porcella SF. Future Microbiology February 2010 5(2) 205-19 -
Antisense phosphorodiamidate morpholino oligomers targeted to an essential gene inhibit Burkholderia cepacia complex
Greenberg DE, Marshall-Batty KR, Brinster LR, Zarember KA, Shaw PA, Mellbye BL, Iversen PL, Holland SM, Geller BL Journal of Infectious Diseases June 2010 201(12) 1822-30 -
Recurrent Burkholderia infection in patients with chronic granulomatous disease: 11-year experience at a large referral center
Greenberg DE, Goldberg JB, Stock F, Murray PR, Holland SM, Lipuma JJ. Clinical Infectious Diseases June 2009 48(11) 1577-9 -
Antisense phosphorodiamidate morpholino oligomers targeted to an essential gene inhibit Burkholderia cepacia complex.
Greenberg DE, Marshall-Batty KR, Brinster LR, Zarember KA, Shaw PA, Mellbye BL, Iversen PL, Holland SM, Geller BL The Journal of infectious diseases 2010 Jun 201 12 1822-30 -
Immune function in young children with previous pulmonary or miliary/meningeal tuberculosis and impact of BCG vaccination.
Sterling TR, Martire T, de Almeida AS, Ding L, Greenberg DE, Moreira LA, Elloumi H, Torres AP, Sant'Anna CC, Calazans E, Paraguassu G, Gebretsadik T, Shintani A, Miller K, Kritski A, Lapa e Silva JR, Holland SM Pediatrics 2007 Oct 120 4 e912-21 -
Genome sequence analysis of the emerging human pathogenic acetic acid bacterium Granulibacter bethesdensis.
Greenberg DE, Porcella SF, Zelazny AM, Virtaneva K, Sturdevant DE, Kupko JJ, Barbian KD, Babar A, Dorward DW, Holland SM Journal of bacteriology 2007 Dec 189 23 8727-36
-
Peptide-conjugated phosphorodiamidate morpholino oligomer (PPMO) restores carbapenem susceptibility to NDM-1-positive pathogens in vitro and in vivo.
Research
- Infections in Immunocompromised Hosts
- Gram-negative Bacterial Infections
- Burkholderia cepacia complex
- Antimicrobial development
- Acinetobacter baumannii
Showing 1 locations
Internal Medicine Subspecialties Clinic
at West Campus Building 3 2001 Inwood Road, 8th and 9th FloorDallas, Texas 75390 214-645-2800 Directions Parking Info